Elucidation of the relationship between methadone blood concentration and CYP2B6 genetic polymorphism and long QT

Elucidation of the relationship between methadone blood concentration and CYP2B6 genetic polymorphism and long QT - Elucidation of the relationship between methadone blood concentration and CYP2B6 genetic polymorphism and long QT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000047862

Enrollment

Registered

2022-05-25

Start date

2022-05-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer pain

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients scheduled to receive methadone for cancer pain and admitted to Tohoku Medical and Pharmaceutical University Hospital

Exclusion criteria

Exclusion criteria: Pregnant women or patients who may be pregnant, Lactating patients

Design outcomes

Primary

Measure	Time frame
methadone blood concentration, QT interval, CYP2B6 phenotype	—

Countries

Japan

Contacts

Public ContactRYUSUKE OUCHI

Tohoku Medical and Pharmaceutical University Division of Clinical Pharmaceutics and Pharmacy Practice

rouchi@tohoku-mpu.ac.jp022-290-8850

Outcome results